Simplex Trading
CNTB

Simplex Trading’s Connect Biopharma Holdings CNTB Stock Holding History

Simplex Trading’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33K Sell
1,400
-1,900
-58% -$4.61K ﹤0.01% 8388
2026
Q1 		$8.65K Buy
3,300
+2,800
+560% +$7.3K ﹤0.01% 7476
2025
Q4 		$1.41K Buy
+500
New +$1.07K ﹤0.01% 7938

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Simplex Trading's CNTB Position: Q2 2026 in Review

Simplex Trading opened a new position in Connect Biopharma Holdings (CNTB) in Q2 2026: 81,948 shares worth $195K. The stake represents ﹤0.01% of the portfolio and ranks #4750 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CNTB as recently as Q4 2025.

Simplex Trading first reported a position in CNTB in Q4 2021 and has held it in 7 quarters since. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Simplex Trading held 81,948 shares of Connect Biopharma Holdings worth $195K as of Q2 2026.
  • Connect Biopharma Holdings was a new Simplex Trading position in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4750 holding.
  • Simplex Trading first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 7 quarters since.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.